Studies in rodent models of diabetic peripheral nerve injury have indicated that blocking pro-inflammatory interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) expressions attenuates neuroinflammatory response and pathological damage [13,14]. The gene discussed is IL6; the disease is peripheral nerve injury.